The global Insulin Pens Market is expected to grow at a CAGR of 6.5% during the period 2023-2033. The market is holding a valuation of US$ 35 billion as of 2023. The market is projected to be valued at US$ 66 billion by 2033. According to Future Market Insights (FMI), the demand for insulin pens is expected to rise considerably in the coming decade, enabling the market to surpass a valuation of US$ 30,407.5 Mn by the end of 2021.
Patients with diabetes use insulin pens to prevent complications, such as cardiovascular illnesses, that could result from this lifestyle-based illness. Insulin pens facilitate and expedite the administration of insulin by addressing issues with traditional techniques. The WHO estimates that diabetes contributed to over 1.2 million deaths worldwide in 2019. The creation of cutting-edge methods and solutions for the management of diabetes is crucial if we are to reduce the number of fatalities or sufferings brought on by the disease.
Request a sample @ https://www.futuremarketinsights.com/reports/sample/rep-gb-13518
Type 2 diabetes cases are common, but it can be prevented or delayed by a healthy diet, consistent physical activity, maintaining a standard body weight and avoiding the use of tobacco. Diabetes can be treated or managed with medicines and regular checking and treatment. Increasing focus on innovative medical products and research are increasingly driving a transition towards insulin pen by diabetes patients. Leading manufacturers in the insulin pen market are strengthening their market position through collaborations with various health and research organizations. Governments in developed and developing countries are actively taking initiatives to encourage innovative medical products.
For instance, in November 2020, Medtronic introduced CGM integrated smart insulin delivery pen to manage multiple daily dosage insulin injections. Similarly, Insulet expanded its offering of OmipodDASH into additional countries such as Sweden, Finland, Norway, and Denmark.
Key Takeaways from Insulin Pen Services Market Study
- Reusable insulin pens are expected to account for over 49% the global market share by 2031, supported by a growing base of environment and cost-conscious consumers.
- Hospital pharmacies will account for 33.8% of the market share in 2031. The soaring influx of patients for treatment and intensive care support supports growth.
- The U.S. is projected to be the fastest-growing regional market with a CAGR of 5.6% through 2021-2031 owing to the matured healthcare sector of the country.
- The U.K. and Germany are leading markets in Europe, accounting for more than 18% and 25% in 2021.
- China is the largest and fastest growing market in East Asia, exhibiting a 4.7% CAGR through 2031.
- Australia is leading the Oceania market, accounting for more than 85% of insulin pen revenues in 2021.
Ask An Analyst: https://www.futuremarketinsights.com/ask-question/rep-gb-13518
Who is Winning?
The global insulin pen market is set to expand due to the rising prevalence of type 1 and type 2 diabetes. Leading organizations within the market are set to focus on research and development to offer an early and precise diagnosis of the ailment, besides offering effective patient care.
Some of the leading players in the insulin pen market include but are not limited to NovoNordisk A/S, Sanofi, Eli Lilly, Diamesco Co., Ltd., BigFoot Biomedical, Inc, Medtronic plc, Emperra GmbH E-Health Technologies, YpsoMed AG, and DUKADA Aps.
Insulin Pens Market by Category
By Product Type:
- Reusable Insulin Pen
- Refillable Pens
- Bluetooth Connected Smart Insulin Pen
- USB Connected Smart Insulin Pen
- Cartridge
- Disposable Insulin Pens
- Smart Insulin Pens Caps
- Insulin Pump
Request Customization@ https://www.futuremarketinsights.com/customization-available/rep-gb-13518
By Indication:
- Type 1
- Type 2
Distribution Channel:
- Hospital Pharmacy
- Retail Pharmacy
- Online Sales
- Diabetes Clinic/Center
Region:
- North America
- Latin America
- Europe
- East Asia
- South Asia
- Oceania
- Middle East and Africa (MEA)
Use promo code >> FMITODAY to get flat 20% discount
Top More Related Reports:
Muscle Stimulation Devices Market
Antibiotic Susceptibility Testing Market
About Future Market Insights (FMI)
Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.
Contact:
Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Browse All Reports: https://www.futuremarketinsights.com/reports
